financetom
Business
financetom
/
Business
/
American Airlines, Target, Others Sue Drugmakers Over Alleged Price-Fixing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
American Airlines, Target, Others Sue Drugmakers Over Alleged Price-Fixing
Apr 5, 2024 11:16 AM

01:57 PM EDT, 04/05/2024 (MT Newswires) -- American Airlines Group ( AAL ) , Target ( TGT ) and several other major employers filed a lawsuit in a federal court alleging several pharmaceuticals making generic drugs of orchestrating a price-fixing that led to increases in drug prices since 2009.

The lawsuit, filed in the US District Court for the Eastern District of Pennsylvania on Thursday, alleges that the defendants, including Pfizer ( PFE ) and Novartis ( NVS ) , also engaged in unlawful activities such as bid rigging, and market allocation of hundreds of generic drugs.

The plaintiffs, all of whom provide health plans to their employees, claim to have suffered billions of dollars in overcharges due to the defendants' illegal conduct.

The lawsuit seeks "injunctive relief and damages" against these manufacturers for the alleged violations of federal and state laws.

American Airlines ( AAL ), Target ( TGT ), Pfizer ( PFE ) and Novartis ( NVS ) did not immediately respond to MT Newswires' requests for comment.

Price: 13.81, Change: -0.02, Percent Change: -0.18

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Mitek Systems' Q3 revenue beats estimates on SaaS strength
Mitek Systems' Q3 revenue beats estimates on SaaS strength
Aug 7, 2025
Overview * Mitek ( MITK ) fiscal Q3 revenue up 2% yr/yr, beating analyst expectations, per LSEG data * SaaS revenue grows 23% yr/yr, indicating strong demand for identity solutions Outlook * Mitek ( MITK ) tightens full-year revenue guidance to $174 mln-$177 mln * Company narrows full-year adjusted EBITDA margin to 28%-29% Result Drivers * SAAS REVENUE GROWTH -...
Cipher Pharma Q2 revenue soars 152%, beating estimates, on strong Natroba sales 
Cipher Pharma Q2 revenue soars 152%, beating estimates, on strong Natroba sales 
Aug 7, 2025
Overview * Cipher Q2 2025 revenue rises 152% yr/yr to quarterly record of $13.4 mln, beats estimates * Adjusted EBITDA for Q2 2025 grows 148% and beats analyst expectations * Company repaid $15 mln debt and repurchased $2.1 mln shares in Q2 2025 Outlook * Cipher aims to grow Natroba market share in U.S. anti-parasitic market * Company intends to...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Onto Innovation Q2 revenue beats estimates
Onto Innovation Q2 revenue beats estimates
Aug 7, 2025
Overview * Onto Innovation ( ONTO ) Q2 revenue rises 5% yr/yr, beating analyst expectations * Adjusted EPS of $1.25 missed analyst estimates, per LSEG data * Company had acquired Semilab product lines for $545 mln Outlook * Onto Innovation ( ONTO ) expects Q3 revenue between $210 mln and $225 mln * Company forecasts Q3 gross margin of 53%...
Copyright 2023-2026 - www.financetom.com All Rights Reserved